Nkarta (NKTX)

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight research firms that are presently covering the stock, Marketbeat.com reports. One res… [+3648 chars]...

Bank of America Corp DE lifted its position in shares of Nkarta, Inc. (NASDAQ:NKTX – Free Report) by 110.1% during the fourth quarter, Holdings Channel reports. The firm owned 380,444 shares of the c… [+3742 chars]...

Hsbc Holdings PLC increased its holdings in shares of Nkarta, Inc. (NASDAQ:NKTX – Free Report) by 102.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 73,845 shares of the c… [+3441 chars]...

Dimensional Fund Advisors LP raised its position in shares of Nkarta, Inc. (NASDAQ:NKTX – Free Report) by 101.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 569,357 shares of the… [+3619 chars]...

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to trea… [+7063 chars]...

Cubist Systematic Strategies LLC reduced its stake in shares of Nkarta, Inc. (NASDAQ:NKTX – Free Report) by 5.4% during the 4th quarter, HoldingsChannel reports. The firm owned 109,906 shares of the … [+3631 chars]...